Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-02 7:18 pm Purchase | 2021-12-31 | 13G | TAKEDA PHARMACEUTICAL CO LTD S TAK | BlackRock Inc. BLK | 104,941,952 6.600% | 5,393,016 (+5.42%) | Filing |
| 2022-01-14 06:07 am Purchase | 2021-12-31 | 13G | XILIO THERAPEUTICS INC XLO | TAKEDA PHARMACEUTICAL CO LTD TAK | 105,366 5.370% | 105,366 (New Position) | Filing History |
| 2022-01-14 06:06 am Sale | 2021-12-31 | 13G | SHATTUCK LABS INC STTK | TAKEDA PHARMACEUTICAL CO LTD TAK | 2,090,858 4.950% | -9,454 (-0.45%) | Filing History |
| 2022-01-14 06:02 am Purchase | 2021-12-31 | 13G | DAY ONE BIOPHARMACEUTICALS INC DAWN | TAKEDA PHARMACEUTICAL CO LTD TAK | 6,012,758 9.700% | 6,012,758 (New Position) | Filing History |
| 2021-11-12 06:03 am Sale | 2021-11-09 | 13D | PHATHOM PHARMACEUTICALS INC CO PHAT | TAKEDA PHARMACEUTICAL CO LTD TAK | 7,459,304 19.200% | -1,212,696 (-13.98%) | Filing History |
| 2021-10-25 06:07 am Sale | 2021-10-19 | 13G | MIRUM PHARMACEUTICALS INC MIRM | TAKEDA PHARMACEUTICAL CO LTD TAK | 530,562 1.700% | -1,328,589 (-71.46%) | Filing History |